GB9005829D0 - Synthetic polypeptides - Google Patents

Synthetic polypeptides

Info

Publication number
GB9005829D0
GB9005829D0 GB909005829A GB9005829A GB9005829D0 GB 9005829 D0 GB9005829 D0 GB 9005829D0 GB 909005829 A GB909005829 A GB 909005829A GB 9005829 A GB9005829 A GB 9005829A GB 9005829 D0 GB9005829 D0 GB 9005829D0
Authority
GB
United Kingdom
Prior art keywords
synthetic polypeptides
polypeptides
synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909005829A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Protherics Medicines Development Ltd
Original Assignee
Proteus Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteus Biotechnology Ltd filed Critical Proteus Biotechnology Ltd
Priority to GB909005829A priority Critical patent/GB9005829D0/en
Publication of GB9005829D0 publication Critical patent/GB9005829D0/en
Priority to EP91906077A priority patent/EP0519986A1/en
Priority to PCT/GB1991/000392 priority patent/WO1991013909A1/en
Priority to NZ237417A priority patent/NZ237417A/en
Priority to AU74679/91A priority patent/AU636735B2/en
Priority to JP3505817A priority patent/JPH05505188A/en
Priority to BR919106159A priority patent/BR9106159A/en
Priority to MX2489091A priority patent/MX24890A/en
Priority to CA002078220A priority patent/CA2078220A1/en
Priority to HU922939A priority patent/HUT63179A/en
Priority to IL97551A priority patent/IL97551A0/en
Priority to ZA911886A priority patent/ZA911886B/en
Priority to APAP/P/1991/000245A priority patent/AP211A/en
Priority to CN91101549A priority patent/CN1054772A/en
Priority to CS91680A priority patent/CS68091A2/en
Priority to FI923800A priority patent/FI923800A/en
Priority to OA60275A priority patent/OA09671A/en
Priority to NO92923573A priority patent/NO923573L/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036Retroviridae, e.g. leukemia viruses
    • C07K16/1045Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
GB909005829A 1990-03-15 1990-03-15 Synthetic polypeptides Pending GB9005829D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GB909005829A GB9005829D0 (en) 1990-03-15 1990-03-15 Synthetic polypeptides
HU922939A HUT63179A (en) 1990-03-15 1991-03-13 Process for producing synthetic polypeptides
CA002078220A CA2078220A1 (en) 1990-03-15 1991-03-13 Synthetic polypeptides
PCT/GB1991/000392 WO1991013909A1 (en) 1990-03-15 1991-03-13 Synthetic polypeptides
NZ237417A NZ237417A (en) 1990-03-15 1991-03-13 Synthetic hiv epitopic peptide (12 aa) and its use
AU74679/91A AU636735B2 (en) 1990-03-15 1991-03-13 Synthetic polypeptides
JP3505817A JPH05505188A (en) 1990-03-15 1991-03-13 synthetic polypeptide
BR919106159A BR9106159A (en) 1990-03-15 1991-03-13 SYNTHETIC POLYPEPTIDE, VACCINE, CASE TO DETECT HIV OR HIV ANTIBODIES, DNA MOLECULE, PHARMACEUTICAL COMPOSITION, ANTIBODY OR FRAGMENT OF THE SAME ANTIGEN, THERAPY PROCESSES OR HIV INFECTION, PROTECTING HIV AND HIV INFECTION, PROTECTING HIV THE MANUFACTURE OF A SYNTHETIC POLYPEPTIDE, PHARMACEUTICAL COMPOSITION AND AN ANTIBODY OR BINDING FRAGMENT OF THE SAME
MX2489091A MX24890A (en) 1990-03-15 1991-03-13 SYNTHETIC POLYPEPTIDE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT.
EP91906077A EP0519986A1 (en) 1990-03-15 1991-03-13 Synthetic polypeptides
APAP/P/1991/000245A AP211A (en) 1990-03-15 1991-03-14 Synthetic polypeptides.
IL97551A IL97551A0 (en) 1990-03-15 1991-03-14 Synthetic polypeptides
ZA911886A ZA911886B (en) 1990-03-15 1991-03-14 Synthetic polypeptides
CN91101549A CN1054772A (en) 1990-03-15 1991-03-15 Synthetic polypeptide
CS91680A CS68091A2 (en) 1990-03-15 1991-03-15 Synthetic polypeptides
FI923800A FI923800A (en) 1990-03-15 1992-08-24 SYNTHETIC POLYPEPTIDER
OA60275A OA09671A (en) 1990-03-15 1992-09-11 Synthetic polypeptides
NO92923573A NO923573L (en) 1990-03-15 1992-09-14 SYNTHETIC POLYPEPTIDES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909005829A GB9005829D0 (en) 1990-03-15 1990-03-15 Synthetic polypeptides

Publications (1)

Publication Number Publication Date
GB9005829D0 true GB9005829D0 (en) 1990-05-09

Family

ID=10672665

Family Applications (1)

Application Number Title Priority Date Filing Date
GB909005829A Pending GB9005829D0 (en) 1990-03-15 1990-03-15 Synthetic polypeptides

Country Status (17)

Country Link
EP (1) EP0519986A1 (en)
JP (1) JPH05505188A (en)
CN (1) CN1054772A (en)
AP (1) AP211A (en)
AU (1) AU636735B2 (en)
BR (1) BR9106159A (en)
CA (1) CA2078220A1 (en)
CS (1) CS68091A2 (en)
FI (1) FI923800A (en)
GB (1) GB9005829D0 (en)
HU (1) HUT63179A (en)
IL (1) IL97551A0 (en)
MX (1) MX24890A (en)
NZ (1) NZ237417A (en)
OA (1) OA09671A (en)
WO (1) WO1991013909A1 (en)
ZA (1) ZA911886B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2099367A1 (en) * 1991-11-04 1993-05-05 Dade International Inc. Synthetic peptides corresponding to portions of hiv-2 virus and methods of using in an improved assay
US5395750A (en) * 1992-02-28 1995-03-07 Hoffmann-La Roche Inc. Methods for producing proteins which bind to predetermined antigens
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
WO1993018006A1 (en) * 1992-03-11 1993-09-16 Narhex Limited Amine derivatives of oxo- and hydroxy-substitued hydrocarbons
DE69333270T2 (en) 1992-03-11 2004-08-05 Narhex Ltd. AMINE DERIVATIVES OF OXO AND HYDROXY SUBSTITUTED CARBON HYDROGEN
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
GB9208428D0 (en) * 1992-04-16 1992-06-03 Proteus Molecular Design Synthetic polypeptides
US6511845B1 (en) 1992-08-07 2003-01-28 Alan R. Davis Methods for producing an immune response against HIV-1
ATE258188T1 (en) 1992-08-27 2004-02-15 Deakin Res Ltd RETRO, INVERSO, AND RETRO-INVERSO SYNTHETIC PEPTIDE ANALOGS
DE4402756A1 (en) * 1994-01-31 1995-08-03 Boehringer Mannheim Gmbh Specific binding substances for antibodies and their use for immunoassays or vaccines
AUPM411994A0 (en) * 1994-02-25 1994-03-24 Deakin Research Limited Epitopes
US6764682B1 (en) * 1994-06-16 2004-07-20 Aventis Pasteur Limited Adjuvant compositions containing more than one adjuvant
US6290971B1 (en) 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
CN1472314A (en) * 2002-07-29 2004-02-04 清华大学 Immunity expression of AIDS virus O and its use
CN100445296C (en) * 2006-03-31 2008-12-24 浙江大学 Polypeptide organic compounds and application in xenogeneic transplantation
CA2743904A1 (en) 2008-11-17 2010-05-20 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same
GB201612108D0 (en) 2016-07-12 2016-08-24 Univ Strathclyde Preperation of non-ionic surfactant vesicles and variants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714802D0 (en) * 1987-06-24 1987-07-29 Proteus Biotech Ltd Synthetic polypeptides
ATE87487T1 (en) * 1987-11-16 1993-04-15 Hoffmann La Roche RECOMBINANT HIV-2 POLYPEPTIDES.

Also Published As

Publication number Publication date
HUT63179A (en) 1993-07-28
HU9202939D0 (en) 1992-12-28
MX24890A (en) 1993-12-01
CS68091A2 (en) 1991-12-17
FI923800A0 (en) 1992-08-24
BR9106159A (en) 1993-03-16
IL97551A0 (en) 1992-06-21
NZ237417A (en) 1993-10-26
CA2078220A1 (en) 1991-09-16
WO1991013909A1 (en) 1991-09-19
ZA911886B (en) 1991-12-24
EP0519986A1 (en) 1992-12-30
CN1054772A (en) 1991-09-25
AP9100245A0 (en) 1991-04-30
JPH05505188A (en) 1993-08-05
AU636735B2 (en) 1993-05-06
AU7467991A (en) 1991-10-10
FI923800A (en) 1992-08-24
OA09671A (en) 1993-05-15
AP211A (en) 1992-10-21

Similar Documents

Publication Publication Date Title
IL95071A0 (en) Synthetic material-bottle
AP9100245A0 (en) Synthetic polypeptides
GB9208428D0 (en) Synthetic polypeptides
EP0447133A3 (en) Paired polypeptides
ZA915978B (en) Peptides
ZW9093A1 (en) Synthetic polypeptides
GB9106674D0 (en) Synthetic polypeptides
ZA929392B (en) Synthetic polypeptides
GB9013773D0 (en) Polypeptides
MW891A1 (en) Polypeptides
GB9016215D0 (en) Polypeptides
ZA935308B (en) Synthetic polypeptides
GB9218163D0 (en) Synthetic polypeptides
GB9214663D0 (en) Synthetic polypeptides
GB9219710D0 (en) Synthetic polypeptides
IE892648L (en) Synthetic polypeptides
ZA914206B (en) Crystalline polypeptides
GB9105871D0 (en) Synthetic peptides
GB8816991D0 (en) Synthetic polypeptides
GB8804656D0 (en) Synthetic polypeptides
GB8816987D0 (en) Synthetic polypeptides
GB8804654D0 (en) Synthetic polypeptides
GB8816989D0 (en) Synthetic polypeptides
GB8816990D0 (en) Synthetic polypeptides
GB8804657D0 (en) Synthetic polypeptides